Get startedLog in
    Picture of Basilea Pharmaceutica AG, Allschwil logo

    BSLN — Basilea Pharmaceutica AG, Allschwil News Story

    0.000.00%
    ch flag iconLast trade - 00:00
    HealthcareAdventurousMid CapHigh Flyer
    All News

    Brief: Basilea Announces Commercial Availability Of Antibiotic In The United States

    Picture of Basilea Pharmaceutica AG, Allschwil logoBasilea Pharmaceutica AG, Allschwil
    20/05/2025 06:17
    May 20 (Reuters) - Basilea Pharmaceutica AG Allschwil BSLN.S:

BASILEA ANNOUNCES COMMERCIAL AVAILABILITY OF ANTIBIOTIC ZEVTERA® (CEFTOBIPROLE) IN THE UNITED STATES

BASILEA PHARMACEUTICA AG ALLSCHWIL - TO RECEIVE ROYALTIES AND UP TO $223 MILLION MILESTONES

BASILEA PHARMACEUTICA AG ALLSCHWIL - AWARDED $111 MILLION FOR PHASE 3 STUDIES COSTS

Source text: ID:nGNE5zWRSL

Further company coverage: BSLN.S

 (Gdansk Newsroom)

 (((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600);))

    Recent news on Basilea Pharmaceutica AG, Allschwil

    See all news